keyword
https://read.qxmd.com/read/38643368/a-review-of-the-topical-management-of-acne-and-its-associated-sequelae-in-the-asia-pacific-region-with-a-spotlight-on-trifarotene
#1
REVIEW
Jo-Ann See, Rajeev Chavda, Khen M Kon, Greg J Goodman, Marie S Oblepias, Rosalia Nadela, Hazel H Oon, Sanjeev Aurangabadkar, Daeh H Suh, Henry H L Chan, Koushik Lahiri
Acne, a highly prevalent skin disease, can be particularly bothersome for patients of Asian background because of its impact on self-confidence and social interactions. In addition to active acne lesions, some patients may develop sequelae such as scarring, macular/postinflammatory hyperpigmentation, or erythema. The tendency of Asian skin to develop sequelae because of its increased susceptibility to irritation, cultural preferences for lighter skin phototypes, and differences in skincare regimens may all contribute to the increased burden of acne...
April 21, 2024: International Journal of Dermatology
https://read.qxmd.com/read/38618753/tazarotene-is-as-effective-and-tolerable-as-imiquimod-in-the-treatment-of-verruca-plana-a-comparative-randomized-clinical-trial
#2
JOURNAL ARTICLE
Hagar Nofal, Fatma Omran, Basma ElKholy, Sara Nofal, Ahmad Nofal
BACKGROUND: Plane warts when multiple and recurrent present a therapeutic challenge acting as a source of reinfection causing frustration and affecting patient's quality of life. For lesions of large numbers in cosmetically significant sites, topical treatment is preferred to avoid potential sequelae. OBJECTIVES: To evaluate and compare the efficacy and tolerability of tazarotene 0.1% gel versus imiquimod 5% cream for the treatment of plane warts. METHODS: In a parallel three-arm randomized controlled trial, 60 patients were randomized into imiquimod, tazarotene or placebo groups...
April 15, 2024: Clinical and Experimental Dermatology
https://read.qxmd.com/read/38572190/vitamins-for-the-management-of-nail-disease-a-literature-review
#3
REVIEW
Kaya L Curtis, Shari R Lipner
BACKGROUND: Vitamins have gained popularity among physicians and patients for purported benefits to hair, skin, and nail health. Safe and efficacious therapies for nail disorders, many of which are chronic conditions, are needed. SUMMARY: We conducted a literature review of studies assessing the efficacy of oral, topical, and intralesional vitamin/vitamin derivatives for the treatment of nail disorders, including yellow nail syndrome, brittle nail syndrome, onychomycosis, habit-tic nail deformity, periungual/subungual verruca, and nail psoriasis...
April 2024: Skin Appendage Disorders
https://read.qxmd.com/read/38467988/atypical-fibroxanthoma-treated-with-a-topical-combination-of-imiquimod-tazarotene-and-5-fluorouracil
#4
JOURNAL ARTICLE
William J Nahm, Evangelos V Badiavas, Robert S Kirsner, Carter J Boyd, Anita A Arthur, Sean Bae, John Shen
This case report describes an 80-year-old man who presented with a growing erythematous nodule with erosion, measuring 0.6 cm × 0.6 cm, on his right temple. This lesion was later diagnosed as atypical fibroxanthoma (AFX). Instead of undergoing Mohs surgery, the gold standard treatment, the patient opted to pursue a topical treatment regimen because of financial costs associated with surgical removal and repair. This topical regimen consisted of tazarotene cream, imiquimod cream, and 5-fluorouracil solution, applied for 30 days...
March 12, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38376392/an-adaptable-drug-delivery-system-facilitates-peripheral-nerve-repair-by-remodeling-the-microenvironment
#5
JOURNAL ARTICLE
Qiang Cheng, Weixing Wang, Xianzhen Dong, Yunhui Chai, Takashi Goto, Rong Tu, Lesan Yan, Aixi Yu, Honglian Dai
The multifaceted process of nerve regeneration following damage remains a significant clinical issue, due to the lack of a favorable regenerative microenvironment and insufficient endogenous biochemical signaling. However, the current nerve grafts have limitations in functionality, as they require a greater capacity to effectively regulate the intricate microenvironment associated with nerve regeneration. In this regard, we proposed the construction of a functional artificial scaffold based on a "two-pronged" approach...
February 20, 2024: Biomacromolecules
https://read.qxmd.com/read/38346503/determining-topical-product-bioequivalence-with-stimulated-raman-scattering-microscopy
#6
JOURNAL ARTICLE
Fotis Iliopoulos, Dandan Tu, Isaac J Pence, Xiaolei Li, Priyanka Ghosh, Markham C Luke, Sam G Raney, Elena Rantou, Conor L Evans
Generic drugs are essential for affordable medicine and improving accessibility to treatments. Bioequivalence (BE) is typically demonstrated by assessing a generic product's pharmacokinetics (PK) relative to a reference-listed drug (RLD). Accurately estimating cutaneous PK (cPK) at or near the site of action can be challenging for locally acting topical products. Certain cPK approaches are available for assessing local bioavailability (BA) in the skin. Stimulated Raman scattering (SRS) microscopy has unique capabilities enabling continuous, high spatial and temporal resolution and quantitative imaging of drugs within the skin...
February 10, 2024: Journal of Controlled Release
https://read.qxmd.com/read/38306148/halobetasol-propionate-0-01-and-tazarotene-0-045-lotion-with-a-ceramide-containing-moisturizer-in-adults-with-psoriasis
#7
JOURNAL ARTICLE
Leon Kircik, Abby Jacobson
INTRODUCTION: Moisturizers are often used as adjuvant therapy for psoriasis to assist with rehydration and skin barrier restoration. Fixed-combination halobetasol propionate 0.01% and tazarotene 0.045% lotion (HP/TAZ) is indicated for the topical treatment of plaque psoriasis in adults, with a demonstrated clinical profile in two phase 3 trials. However, the effect of application order with HP/TAZ has yet to be explored. This study evaluated the clinical profile of HP/TAZ applied before versus after a ceramide-containing moisturizer in adults with mild-to-moderate plaque psoriasis...
February 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38300170/guidelines-of-care-for-the-management-of-acne-vulgaris
#8
JOURNAL ARTICLE
Rachel V Reynolds, Howa Yeung, Carol E Cheng, Fran Cook-Bolden, Seemal R Desai, Kelly Druby, Esther E Freeman, Jonette E Keri, Linda F Stein Gold, Jerry K L Tan, Megha M Tollefson, Jonathan S Weiss, Peggy A Wu, Andrea L Zaenglein, Jung Min Han, John S Barbieri
BACKGROUND: Acne vulgaris commonly affects adults, adolescents, and preadolescents aged 9 years or older. OBJECTIVE: The objective of this study was to provide evidence-based recommendations for the management of acne. METHODS: A work group conducted a systematic review and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of evidence and formulating and grading recommendations...
January 30, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38299457/efficacy-of-ceramides-and-niacinamide-containing-moisturizer-versus-hydrophilic-cream-in-combination-with-topical-anti-acne-treatment-in-mild-to-moderate-acne-vulgaris-a-split-face-double-blinded-randomized-controlled-trial
#9
JOURNAL ARTICLE
Therdpong Tempark, Andrew Shem, Suparuj Lueangarun
INTRODUCTION: Topical therapy is the mainstay treatment of acne, and topical retinoids such as tretinoin, tazarotene, and adapalene are recommended as the first-line therapy for mild to moderate acne. However, the cutaneous irritations may occur, and the dermocosmetics are recommended to prevent side effects of anti-acne drugs and adhere to treatment. Thus, this study aims to compare the efficacy and tolerability of ceramides and niacinamide-containing moisturizer (CCM) versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris...
February 1, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38294764/drugs-for-acne
#10
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 5, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38279612/injectable-hydrogel-system-incorporating-black-phosphorus-nanosheets-and-tazarotene-drug-for-enhanced-vascular-and-nerve-regeneration-in-spinal-cord-injury-repair
#11
JOURNAL ARTICLE
Kun Liu, Yue Wang, Xianzhen Dong, Chao Xu, Meng Yuan, Wenying Wei, Zixuan Pang, Xiaopei Wu, Honglian Dai
Spinal cord injury (SCI) often leads to cell death, vascular disruption, axonal signal interruption, and permanent functional damage. Currently, there are no clearly effective therapeutic options available for SCI. Considering the inhospitable SCI milieu typified by ischemia, hypoxia, and restricted neural regeneration, a novel injectable hydrogel system containing conductive black phosphorus (BP) nanosheets within a lipoic acid-modified chitosan hydrogel matrix (LAMC) is explored. The incorporation of tannic acid (TA)-modified BP nanosheets (BP@TA) into the LAMC hydrogel matrix significantly improved its conductivity...
January 26, 2024: Small
https://read.qxmd.com/read/38258075/transdermal-drug-delivery-of-tazarotene-determining-tazarotene-s-potential-in-local-transdermal-therapy
#12
JOURNAL ARTICLE
Helena Hamzehpour, Ástrós Óskarsdóttir, Helgi Jónsson, Fjóla Jónsdóttir, Ólafur E Sigurjónsson, Bergthora S Snorradottir
Retinoid-based drugs, while effective, are associated with systemic toxicity. Topical alternatives offer a safer option, and tazarotene, a third-generation synthetic retinoid, holds promise. This study investigates tazarotene's transdermal delivery potential, focusing on its application for joint-related conditions. The aim of this study was to investigate the suitability of tazarotene as a candidate for transdermal delivery into joints. In vitro permeation studies, using porcine skin, assessed tazarotene's transdermal drug delivery from solution and gel formulations...
December 31, 2023: Pharmaceutics
https://read.qxmd.com/read/38240827/a-focused-review-on-laser-and-energy-assisted-drug-delivery-for-nail-disorders
#13
REVIEW
Hailey Konisky, Raquel Klinger, Lesley Coe, Jose A Jaller, Joel L Cohen, Kseniya Kobets
The purpose of this review is to consolidate and summarize laser-assisted drug delivery (LADD) for nail diseases, particularly onychomycosis and psoriasis. A PubMed search was conducted in June 2023 using search terms (1) "laser assisted drug delivery" AND "nail," (2) "laser" AND "nail," and (3) "nail disorder" AND "laser treatment." References of papers were also reviewed, yielding 15 papers for this review. Fractional ablative CO2 laser (FACL) and Er:YAG laser can be used for LADD of topical medications such as amorolfine, terbinafine, and tioconazole to treat onychomycosis...
January 19, 2024: Lasers in Medical Science
https://read.qxmd.com/read/38215417/psoriasis-recognition-and-management-strategies
#14
JOURNAL ARTICLE
Kathryn K Garner, Kattie D S Hoy, Adriana M Carpenter
Psoriasis is an inflammatory skin and systemic disorder that affects 3.2% of the U.S. population, including 1% of children. It is an immune-mediated process triggered by an interplay of genetic, environmental, physical (e.g., skin trauma), and infectious factors. Associated comorbidities include cardiovascular disease, obesity, metabolic syndrome, diabetes mellitus, and inflammatory bowel disease. Psoriasis presents in various forms, including plaque, guttate, erythrodermic, pustular, inverse, nail, and psoriatic arthritis...
December 2023: American Family Physician
https://read.qxmd.com/read/37943277/topical-treatments-for-melasma-and-post-inflammatory-hyperpigmentation
#15
JOURNAL ARTICLE
Neil Sadick, Sukhmani Pannu, Zehara Abidi, Suleima Arruda
BACKGROUND: Dyschromia is one of the most common reasons for patients to seek dermatological care, especially among individuals with skin of color. Most cases present as melasma or post-inflammatory hyperpigmentation (PIH); both are chronic issues requiring long-term treatment. While many pharmaceutical (topical or systemic) or procedural (lasers/chemical peels) options are available, some treatments are not safe/tolerable for long-term use or can induce/exacerbate PIH.  Methods: This qualitative review provides an overview of topical treatments for melasma and PIH, including recent data from an investigator-initiated trial of the retinoid tazarotene...
November 1, 2023: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/37908643/childhood-guttate-psoriasis-an-updated-review
#16
REVIEW
Alexander Kc Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong
BACKGROUND: Guttate psoriasis is common and affects 0.5-2% of individuals in the paediatric age group. This review aims to familiarize physicians with the clinical manifestations, evaluation, diagnosis and proper management of guttate psoriasis. METHODS: A search was conducted in July 2023 in PubMed Clinical Queries using the key term "guttate psoriasis". The search strategy included all observational studies, clinical trials and reviews published within the past 10 years...
2023: Drugs in Context
https://read.qxmd.com/read/37745732/noncorticosteroid-topical-therapies-for-the-treatment-of-plaque-psoriasis-a-narrative-review
#17
REVIEW
Rithi J Chandy, Diem-Phuong D Dao, Cristian C Rivis, Divya M Shan, Steven R Feldman
Objective: The objective was to compare the safety and efficacy of noncorticosteroid topical treatments for plaque psoriasis. Data Sources: A literature search of the PubMed database was performed (January 1978 to May 2023) using the keywords plaque psoriasis , tapinarof, benvitimod, Vtama, roflumilast, Zoryve, pimecrolimus, tacrolimus, tazarotene, tacalcitol, calcitriol, Vectical, calcipotriene, Dovonex, tacalcitol, vitamin D analogs, salicylic acid, non-corticosteroid topical, Investigator's Global Assessment , and Physician's Global Assessment ...
October 2023: Journal of Pharmacy Technology: JPT: Official Publication of the Association of Pharmacy Technicians
https://read.qxmd.com/read/37734108/a-practical-guide-to-advanced-topical-drug-delivery-systems-in-dermatology
#18
REVIEW
Andrei Metelitsa, Isabelle Delorme, Daniel O'Sullivan, Rami Zeinab, Mark Legault, Melinda Gooderham
Dermatological diseases such as atopic dermatitis, acne, and psoriasis result in significant morbidity and decreased quality of life. The first line of treatment for such diseases is often topical medications. While topical delivery allows active drug to be delivered directly to the target site, the skin is a virtually impermeable barrier that impedes delivery of large molecules. Thus, the formulation and delivery system are integral elements of topical medications. Patients also have preferences for the properties of topical formulations and these preferences can positively or negatively impact adherence...
September 2023: Skin Therapy Letter
https://read.qxmd.com/read/37720201/influence-of-season-on-efficacy-and-tolerability-of-tazarotene-0-045-lotion-for-the-treatment-of-acne
#19
JOURNAL ARTICLE
Jerry Tan, Zoe D Draelos, Melinda J Gooderham, Andrew F Alexis, Emmy Graber, Jonette Keri, Heather C Woolery-Lloyd, Julie C Harper, Fran E Cook-Bolden, Adarsh Konda, Emil A Tanghetti
OBJECTIVE: The condition of the skin can vary due to weather fluctuations. Therefore, this post-hoc analysis evaluated efficacy and safety of tazarotene 0.045% lotion in warmer versus colder months. METHODS: In two Phase III, double-blind, 12-week studies, participants aged nine years or older with moderate-to-severe acne were randomized 1:1 to once-daily tazarotene or vehicle lotion. The pooled population (N=1,614) was stratified by randomization date (warmer=May to September; colder=October to April)...
September 2023: Journal of Clinical and Aesthetic Dermatology
https://read.qxmd.com/read/37683070/topical-treatments-for-photoaged-skin
#20
REVIEW
Neil Sadick, Sukhmani Pannu, Zehara Abidi, Suleima Arruda
BACKGROUND: Photoaging due to cumulative lifetime ultraviolet light exposure is the greatest contributing factor to facial aging. With the continued growth of the population of individuals aged ≥65 years and over, demand for safe and effective photoaging treatments will likely increase. METHODS: This qualitative review provides an overview of efficacy and safety of over-the-counter (OTC) and prescription topical treatments for photoaging, including recent data from an investigator-initiated trial of the topical retinoid tazarotene...
September 1, 2023: Journal of Drugs in Dermatology: JDD
keyword
keyword
36379
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.